Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 6 of 383 for:    LENALIDOMIDE AND Dexamethasone

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01816620
Recruitment Status : Completed
First Posted : March 22, 2013
Last Update Posted : April 25, 2017
Celgene Corporation
Information provided by (Responsible Party):
Jian Li, Peking Union Medical College Hospital

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : October 2015
Actual Study Completion Date : April 2017
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 14, 2017
(Canceled - Date Unknown)
May 14, 2017
(Canceled - Date Unknown)
May 14, 2017
October 6, 2017